Funded Local Who is raising money in your own backyard?

Forbes Medi-Tech Inc.
"A Life Sciences Company"

Forbes Medi-Tech Inc. is a life sciences company dedicated to the research, development and commercialization of innovative products for the prevention and treatment of life-threatening disease. Our strategy and vision is to develop and market a portfolio of products for the benefit of all consumers, from the healthy person desiring consumer lifestyle products that can help reduce the risk of future disease, to medical patients needing therapeutic prescription products for the treatment of an established ailment.

Since the Company's inception in 1992, Forbes has made important technological advances in the development of innovative sterol-based products that offer significant commercial opportunities in two distinct markets:

Nutraceutical Products: Reducol™ is a clinically proven cholesterol-lowering ingredient for use in functional foods and dietary supplements.

Prescription Pharmaceuticals: Forbes is developing FM-VP4, a prescription therapeutic, for the prevention and treatment of cardiovascular disease through the reduction of cholesterol.

Forbes is pursuing a common strategy in each of these areas:

Competitive advantage through technology: Proprietary technologies provide Forbes with product or process advantages over existing competition.

Targeting significant markets: Forbes focuses the development of its technology within markets that offer significant potential. Each of its target markets currently represents a multi-billion dollar global market.

Commercialization through strategic partnerships and business associations: The Company believes that leveraging its technology through strategic partnerships and business associations will accelerate commercialization and maximize the chances of success.